Experiments were designed to test the hypothesis that LHRH receptors in the preoptic area (POA) are of physiological importance for maintaining estrous cyclicity in the rat. Bilateral cannulae were implanted just dorsal to the POA. Estrous cycles were monitored daily by vaginal smears. Antide, a long-acting LHRH antagonist, was infused bilaterally (2.5 jig/side) in the POA or the hypothalamus on the mornings of diestrus I and II. As controls, at separate times, rats also received similar infusions of either vehicle (1:1 water:propylene glycol) or a bombesin antagonist (#B0650; Sigma, St. Louis, MO). Collection of daily vaginal smears continued, and the number of days from the first infusion to the next day of estrus that preceded a normal cycle was recorded. After infusion of Antide into the POA, rats demonstrated varying durations of interrupted cycles ranging from 11 days to more than 100 days. These periods of disruption were characterized by either long periods of diestrus, long periods of estrus, or an extended period of diestrus followed by an extended period of estrus. After infusion of Antide into the dorsomedial, ventromedial, or anterior hypothalamic areas, rats had either a 4-or 5-day estrous cycle and continued to cycle normally. Likewise, infusions into the septum had no effect. Infusion of vehicle or bombesin antagonist into any of the hypothalamic or POA sites tested also resulted in no interruptions in the cyclic activity of the rats. Therefore, it appears that functional LHRH receptors in the POA are necessary to drive the normal estrous cycle.
INTRODUCTION
The pulsatile release of LH from the pituitary is tightly coupled to the pulsatile release of LHRH into the hypothalamic-hypophyseal portal system in the rat. Presumably, a pulse of LHRH is achieved by the synchronous discharge of many LHRH neurons. While an immortalized, LHRH-secreting neuronal cell line appears to generate pulses in vitro [1] , it is not known how individual LHRH neurons in vivo could synchronize their secretion with numerous other LHRH neurons. One possibility is that individual LHRH neurons, distributed throughout the preoptic area (POA), communicate with each other to coordinate their firing patterns. This is supported by reports of LHRH neurons making synaptic contact with each other in the POA [2] [3] [4] [5] . Additionally, studies have demonstrated that central administration of LHRH can influence secretion of LHRH in vivo [6] [7] [8] [9] and in vitro [7, 10] .
With these points in mind, it was hypothesized that synchronized activity of individual LHRH neurons may depend on receptor-mediated actions of LHRH itself. If the LHRH decapeptide is indeed an integral part of the LHRH pulse generator [11] , then administration of an LHRH antagonist in the vicinity of LHRH cell bodies should disrupt their ability to regulate a normal estrous cycle. Therefore, the purpose of the present project was to test the idea that LHRH released in the POA is itself a regulator of LHRH release in the median eminence.
MATERIALS AND METHODS

Animals
Female Sprague-Dawley rats (230-260 g) were maintained on a 14L:10OD schedule under standard laboratory conditions. Under pentobarbital anesthesia (40-50 mg/kg), bilateral 22-gauge stainless steel guide cannulae were stereotaxically implanted into the rostral POA (0.1 mm caudal to bregma, 7.6 mm ventral to top of skull, 0.75 mm lateral to midline; n = 10) or into control sites: the dorsomedial (3.0 mm caudal, 7.7 mm ventral, 0.5 mm lateral; n = 2) or ventromedial (2.7 mm caudal, 9.0 mm ventral, 0.6 mm lateral; n = 4) hypothalamic areas [12] . Matching infusion cannulae (28 gauge) were constructed to project 0.5 mm beyond the guide cannula. After recovery from surgery, daily vaginal smears were collected from each rat. Only those rats displaying at least two consecutive 4-day estrous cycles were further utilized in the study. After all treatments, animals were killed and cannulation sites verified histologically. In addition to the rats listed above, six rats had cannulae inadvertently placed into the septum and two rats had cannulae into the anterior hypothalamic area. The results for these rats are included in the present report.
Treatments
On the morning of diestrus I, rats received an intracerebral infusion of the LHRH antagonist, Antide (Sigma, St. Louis, MO; 2.5 ig/side), or a control infusion. Antide has been previously characterized as a pure LHRH antagonist with a long half-life and negligible histamine-releasing properties [13] [14] [15] [16] [17] [18] [19] . Control infusions consisted of either vehicle (1:1 water:propylene glycol) or a bombesin antagonist (Sigma #B0650; 2.5 ,Ig/side) in the same vehicle. The total infu- Table 1 ). Infusion of Antide caused persistent vaginal diestrus, while the control infusion had no effect. Abbreviations: Est = estrus; Pro = proestrus; Di2 = diestrus II; Di = diestrus I; * = day of infusion.
Days
FIG.
3. An example of rostral POA infusions of LHRH antagonist and vehicle. In this animal (rat #42, Table 1 ), Antide caused persistent vaginal estrus while the control infusion had no effect. Vaginal smears were collected for 105 days from this rat. Abbreviations as in Figure 1 .
number of days following infusion until the next estrous cycle. The effects compared were POA infusion of Antide vs. POA infusion of control and hypothalamic infusion of sion volume (0.5 l/side) was delivered over a period of 2 min. On the following morning, diestrus II, rats received an identical infusion. Collection of daily vaginal smears was continued by an investigator blind to the treatment group. The number of days from the first infusion to the next day of estrus that preceded a normal 4-day cycle was recorded. With this method, a rat not responding to the infusions will have a 4-day estrous cycle. After rats resumed normal cycles, the opposite treatment was administered. All rats were assigned to receive Antide and control infusions in random order.
In preliminary trials, infusions of either 1 Ig or 2 Rg of Antide into the POA per treatment day yielded marginal and/ or inconsistent responses among the rats. However, administration of 5 g Antide/infusion yielded robust and repeatable responses, and this dosage was used for all data reported herein.
Statistics
With each rat serving as its own control, the nonparametric Wilcoxon Signed Rank test was used to compare the Table 1 ). Antide caused persistent diestrus while the bombesin antagonist had no effect on estrous cyclicity. Abbreviations as in Figure 1 .
A. 
aAcross all POA infusions, number of days was greater for Antide than for control infusions p < 0.01). No treatment differences were observed in either the septum or hypothalamic sites. bOf the total days, number of days in diestrus (D) and estrus (E).
CThe effects of vehicle and bombesin antagonist infusions were not different and are listed in the same column. dDorsomedial, ventromedial, and anterior hypothalamic areas.
Antide vs. hypothalamic infusion of control. The nonparametric Wilcoxon Rank Sum test was used to compare the effects of POA infusion of Antide vs. hypothalamic infusion of Antide.
RESULTS
Infusions into the POA
After infusion of Antide into the POA, rats displayed varying durations of interrupted estrous cycles ranging from 11 days to more than 100 days. These periods of disruption were characterized by either long periods of diestrus (Figs. 1 and 2), long periods of estrus (Fig. 3) , or an extended Table 1 ). There was no effect of these infusions in any of the hypothalamic regions (control sites) tested. Daily vaginal smears were collected for 69 days from this rat. Abbreviations as in Figure 1 . period of diestrus followed by an extended period of estrus. These effects of Antide are in contrast (p < 0.01) to the effects of infusing vehicle and bombesin antagonist into the POA, after which rats consistently displayed a 4-day (or occasionally a 5-day) cycle. Infusion sites for all rats are shown in Figure 4 , and the responses of all rats are presented in Table 1 .
Infusions into the Hypothalamus
Hypothalamic sites were included as controls for possible diffusion to the pituitary via the third ventricle and/ or the median eminence. Following infusion of Antide into the dorsomedial (n = 4), ventromedial (n = 2), or anterior (n = 2) hypothalamic areas, rats had either a 4-or 5-day estrous cycle and continued to cycle normally (p > 0.25, Fig. 5 ). Also, six rats had cannulae implanted dorsal to the POA (septal area), and these rats showed no response to Table  1 ) demonstrates, these infusions in the septum had no effect on estrous cyclicity. Abbreviations as in Figure 1 .
infusion of the LHRH antagonist (p > 0.25, Fig. 6 ). Infusion of vehicle or bombesin antagonist into any of the hypothalamic (n = 8) or septal (n = 6) sites tested also resulted in no interruptions (p > 0.25, Figs. 5 and 6) in the estrous cyclicity of the rats.
DISCUSSION
In addition to sending axons to the stalk median eminence, LHRH neurons in the POA make synaptic connection with other LHRH neurons in the POA as well with some unidentified cells [3] [4] [5] . The presence of LHRH peptide in presynaptic vesicles, synapsing onto LHRH-containing neuronal perikarya, leads to the speculation that LHRH neurons indeed communicate with each other in the POA and use the decapeptide in a manner that involves LHRH receptors. Though LHRH binding sites have been identified in various brain regions [20] [21] [22] , the difficult task of localizing LHRH receptors on individual LHRH neurons has not yet been accomplished.
In the current study, infusion of a long-acting LHRH antagonist in the region of LHRH cell bodies resulted in disruption of normal estrous cyclicity for several days. This effect is similar to what one might have expected if Antide were blocking pituitary LHRH receptors [16, 23] . However, the hypothalamic infusions in the current study demonstrate that the effect we observed is localized in the POA and is not the result of diffusion to the pituitary. Antide had no effect when infused into the areas in and around the ventromedial nucleus of the hypothalamus and the dorsomedial nucleus of the hypothalamus-sites physically closer to the third ventricle and the hypothalamic-hypophyseal portal system than the POA (see Fig. 4 ). Also, it seems unlikely that the Antide was being delivered to the pituitary by diffusing through the organum vasculosum of the lamina terminalis (OVLT) to the general circulation, because the dose we administered was less than 1% of systemic doses required to achieve similar effects.
It is most likely that the cessation of estrous cyclicity following Antide administration in the POA is attributable to disruption of LHRH release subsequent to blocking LHRH receptors in the POA. Therefore, it appears that functional connectivity between LHRH neurons, and perhaps other POA cells receiving LHRH inputs, is required for generation of infundibular LHRH pulses whose magnitudes and timing produce biologically effective concentrations of LHRH for the pituitary.
During the study, some of the rats whose estrous cycles were disrupted by POA infusion of Antide were examined for sexual receptivity. Those showing persistent vaginal diestrus, indicative of lack of circulating estrogen, showed no lordosis behavior in response to manual stimulationalso indicative of low estrogen. However, rats with persistent vaginal estrus, consistent with the presence of circulating estrogen, exhibited lordosis posture in response to manual stimulation.
The results in these experiments are consistent with the hypothesis that individual LHRH neurons communicate with each other, via LHRH receptors in the POA, to coordinate their firing patterns for a bolus release of LHRH into the hypothalamic-hypophyseal portal system. The hypothesis is also supported by other studies examining LHRH/LH release following central administration of LHRH or its analogues. In general, intracerebroventricular administration of LHRH (or an agonist) to gonadectomized animals results in decreased LHRH and LH release [6, 7, 9] . According to the idea that POA-released LHRH coordinates its own temporal pulses of infundibular LHRH (and thus LH), exogenously administered LHRH would be likely to cause asynchrony among the individual LHRH neurons, thus disrupting the release of LHRH from the median eminence. Alternatively, during the afternoon of proestrus, administration of LHRH into the medial POA has been shown to advance the preovulatory LH surge [8] . It seems that in addition to sensitizing the pituitary to the stimulatory effects of LHRH, the proestrous rise in estrogen may also sensitize the POA to the stimulatory effects of LHRH.
Finally, the results of the present study invite additional interpretations of other studies utilizing Antide. Systemically administered Antide has been shown in numerous reports to decrease serum concentrations of LH, FSH, and gonadal steroids-presumably by blocking LHRH receptors in the pituitary [13, 15, 16, 24] . If Antide diffuses into the brain, either by crossing the blood-brain barrier or passing through the OVLT, the current results indicate that the POA may be an additional site of action for systemically administered Antide to suppress reproductive function.
